Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Gastroenterology Research and Practice|January 2, 2019
How the BRAF V600E Mutation Defines a Distinct Subgroup of Colorectal Cancer: Molecular and Clinical ImplicationsCatherine E Bond, Vicki L J Whitehall
Cancers|February 11, 2023
The Efficacy of Using Patient-Derived Organoids to Predict Treatment Response in Colorectal CancerChang Su, Kelly A Olsen, Catherine E Bond, et al.
Plos One|October 31, 2012
Chromosomal instability in BRAF mutant, microsatellite stable colorectal cancersCatherine E Bond, Aarti Umapathy, Ron L Buttenshaw, et al.
BMC Cancer|January 24, 2015
Methylation and expression of the tumour suppressor, PRDM5, in colorectal cancer and polyp subgroupsCatherine E Bond, Mark L Bettington, Sally-Ann Pearson, et al.
British Journal of Cancer|March 30, 2021
Aspirin reduces the incidence of metastasis in a pre-clinical study of Braf mutant serrated colorectal neoplasiaAlexandra M Kane, Cheng Liu, Lochlan J Fennell, et al.
Oncotarget|September 24, 2016
RNF43 and ZNRF3 are commonly altered in serrated pathway colorectal tumorigenesisCatherine E Bond, Diane M McKeone, Murugan Kalimutho, et al.
International Journal of Cancer|May 11, 2011
p53 mutation is common in microsatellite stable, BRAF mutant colorectal cancersCatherine E Bond, Aarti Umapathy, Ingunn Ramsnes, et al.
Pageof 2